Blueprint Medicines Corporation
US ˙ NasdaqGS ˙ US09627Y1091
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

SecurityBPMC / Blueprint Medicines Corporation
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership14,500 shares
Latest Disclosed Value $ 1,469,575
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.49% increase in ownership of BPMC / Blueprint Medicines Corporation

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 14,500 shares of Blueprint Medicines Corporation (US:BPMC) valued at $1,469,575 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 14,430 shares of Blueprint Medicines Corporation. This represents a change in shares of 0.49% during the quarter. The current value of the position is $1,877,170 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP BLUEPRINT MEDICINES EC US09627Y1091 14,500 70 0.49 1,470 5.46 0.0194
2025-04-25 2025-02-28 NP BLUEPRINT MEDICINES EC US09627Y1091 14,430 378 2.69 1,394 2.88 0.0188
2025-01-27 2024-11-30 NP BLUEPRINT MEDICINES EC US09627Y1091 14,052 -2,413 -14.66 1,354 -13.92 0.0184
2024-10-29 2024-08-31 NP BLUEPRINT MEDICINES EC US09627Y1091 16,465 -336 -2.00 1,573 -11.28 0.0233
2024-07-26 2024-05-31 NP BLUEPRINT MEDICINES EC US09627Y1091 16,801 -656 -3.76 1,774 8.64 0.0281
2024-04-24 2024-02-29 NP BLUEPRINT MEDICINES EC US09627Y1091 17,457 279 1.62 1,633 36.45 0.0273
2024-01-24 2023-11-30 NP BLUEPRINT MEDICINES EC US09627Y1091 17,178 -581 -3.27 1,196 35.14 0.0229
2023-10-27 2023-08-31 NP BLUEPRINT MEDICINES EC US09627Y1091 17,759 1,945 12.30 885 -0.90 0.0173
2023-07-26 2023-05-31 NP BLUEPRINT MEDICINES EC US09627Y1091 15,814 48 0.30 894 33.68 0.0193
2023-04-27 2023-02-28 NP BLUEPRINT MEDICINES EC US09627Y1091 15,766 360 2.34 668 -9.24 0.0163
2023-01-26 2022-11-30 NP BLUEPRINT MEDICINES EC US09627Y1091 15,406 376 2.50 736 -33.09 0.0184
2022-10-26 2022-08-31 NP BLUEPRINT MEDICINES EC US09627Y1091 15,030 3,407 29.31 1,100 72.14 0.0275
2022-07-29 2022-05-31 NP BLUEPRINT MEDICINES EC US09627Y1091 11,623 364 3.23 639 -6.17 0.0163
2022-04-28 2022-02-28 NP BLUEPRINT MEDICINES EC US09627Y1091 11,259 -2,045 -15.37 682 -46.76 0.0158
2022-01-25 2021-11-30 NP BLUEPRINT MEDICINES EC US09627Y1091 13,304 344 2.65 1,280 5.88 0.0267
2021-10-26 2021-08-31 NP BLUEPRINT MEDICINES EC US09627Y1091 12,960 264 2.08 1,209 4.23 0.0265
2021-07-22 2021-05-31 NP BLUEPRINT MEDICINES EC US09627Y1091 12,696 48 0.38 1,160 -6.68 0.0288
2021-04-23 2021-02-28 NP BLUEPRINT MEDICINES EC US09627Y1091 12,648 720 6.04 1,242 -3.65 0.0324
2021-01-20 2020-11-30 NP BLUEPRINT MEDICINES EC US09627Y1091 11,928 713 6.36 1,289 48.50 0.0385
2020-10-16 2020-08-31 NP BLUEPRINT MEDICINES EC US09627Y1091 11,215 195 1.77 868 21.06 0.0268
2020-07-20 2020-05-31 NP BLUEPRINT MEDICINES EC US09627Y1091 11,020 2,454 28.65 718 54.86 0.0280
2020-04-24 2020-02-29 NP BLUEPRINT MEDICINES EC US09627Y1091 8,566 790 10.16 464 -27.32 0.0207
2020-01-16 2019-11-30 NP BLUEPRINT MEDICINES EC US09627Y1091 7,776 7,776 638 0.0290
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.